Insulin lispro Subcutaneous and Pyridostigmine Extended-Release Tablets
Determining the interaction of Insulin lispro Subcutaneous and Pyridostigmine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: pyridostigmine
Brand name: Mestinon, Mestinon Timespan, Regonol
Synonyms: Pyridostigmine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Pyridostigmine Injection
- Insulin lispro Subcutaneous-Pyridostigmine Liquid
- Insulin lispro Subcutaneous-Pyridostigmine Oral Solution
- Insulin lispro Subcutaneous-Pyridostigmine Tablets
- Insulin lispro Subcutaneous-Pyridoxine
- Insulin lispro Subcutaneous-Pyridoxine (Vitamin B6) Capsules and Tablets
- Pyridostigmine Extended-Release Tablets-Insulin NPH
- Pyridostigmine Extended-Release Tablets-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Pyridostigmine Extended-Release Tablets-Insulin NPH (Vials)
- Pyridostigmine Extended-Release Tablets-Insulin NPH and Insulin Regular
- Pyridostigmine Extended-Release Tablets-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Pyridostigmine Extended-Release Tablets-Insulin NPH and Insulin Regular (Vials)